Chemical Structure (Asclera 01)
Asclera Injection, Solution
Product Images NDC 67850-141
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Asclera (NDC 67850-141). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Methapharm, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (10 mg Ampule Carton)
ASCLERA (polidocanol) Injection is a medication that comes in an ampule containing 10 mg of Polidocanol, Ethanol 84 mg (36%), potassium dihydrogen phosphate 0.86 mg, disodium hydrogen phosphate dihydrate 2.4 mg and water for Injection. It is used intravenously and is only for single-use. The dosage information can be found in the package insert. It should be stored at 15° G 10 30° C (59° F to 86° F). Unused portions should be discarded. It is distributed by Mathapharm, Inc. and can be reached at the toll-free number 1-833-756-8345 or the website www.ascleser.com.*
Principal Display Panel (20 mg Ampule Carton)
ASCLERA is an injection medication containing 20 mg of Polidocanol, Ethanol, potassium dihydrogen phosphate, disodium hydrogen phosphate dihydrate, and water for injection. It is distributed by Specialty Pharmaceuticals, Boca Raton, Florida, and it should be stored at 15-30°C (59-86°F). ASCLERA is intended for intravenous use only, and the dosage information is available in the package insert. NDC number for ASCLERA is 67850-141-05. The SN, EXP, and LOT numbers are not available.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
